-Down to Earth India imports around 90 per cent of APIs used to make antibiotics, says an expert The novel coronavirus disease (COVID-19) pandemic has revealed India’s overdependence on China for active pharmaceutical ingredients (APIs) — also known as bulk drugs — defined by the World Health Organization as any substances used in finished pharmaceutical products. India’s pharmaceutical industry is the third-largest in the world in terms of volume. Two-thirds of the total imports...

-The Telegraph India's high dependence on imported active pharmaceutical ingredients is the result of its own failures and astute Chinese policies India’s pharmaceutical industry imports over 70 per cent of key chemical ingredients and will find it challenging to heed Prime Minister Narendra Modi’s call on Tuesday for self-reliance across sectors, experts said. India’s high dependence on imported active pharmaceutical ingredients (APIs) has been the outcome of Chinese policies designed to dominate the...

-The Hindu Study raises safety, efficacy concerns; call for ban of irrational formulations Of the 110 anti-TB (tuberculosis) Fixed Dose Combinations (FDCs) available in India, only 32 (less than 30%) have been approved by the Central Drugs Standard Control Organisation (CDSCO), the country’s drug regulator. In the case of malaria FDCs, only eight out of 20 (40%), have been approved. These statistics, that give rise to safety and efficacy concerns, have been brought...

-PTI NEW DELHI: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 per cent, Parliament was informed today. In a written reply in Lok Sabha, Minister of State, Chemicals and Fertilisers Mansukh L Mandaviya said the other four major countries from where India imports bulk drugs are Germany, the US, Italy and Singapore. India's import of active pharmaceutical ingredients (API) from China...

-Livemint.com Govt plans to?help firms revamp manufacturing units,?refurbish machinery,?ensure subsidized power in bid to produce drugs such as penicillin at competitive rates New Delhi: The Department of Pharmaceuticals (DoP), during a meeting on Wednesday, urged pharma companies to strive for self-sufficiency in critical drugs like penicillin, rifampicin and insulin, in a sign of government concern over India’s dependence on Chinese imports. A large number of so-called active pharmaceutical ingredients (APIs), or bulk drugs,...